跳至主要内容
临床试验/NCT00243607
NCT00243607已完成不适用

Prospective Randomized Feasibility Study on the Self Application of Hydrotherapy to Treat Menopausal Symptoms Caused by Breast Cancer Therapy

Heidelberg University1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2006年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
45
试验地点
1
主要终点
Menopausal complaints (MRS II)

研究概览

简要总结

Breast cancer survivors often suffer from climacteric symptoms caused by treatment or diagnosis of their disease.

Hormone replacement therapy is contraindicated and other pharmacological options may also include the risk of stimulating hormone receptors. Hydrotherapy following the guidelines of naturopathy by S. Kneipp is a non-pharmacological treatment option which may influence climacteric symptoms by affecting the regulation of body temperature. In this study, the regular self application of hydrotherapy after initial training by a professional will be evaluated for its efficacy, practicability, and compatibility.

详细描述

Patients should use 2-5 different treatment options per day and fulfill a diary for symptoms and adherence to self-treatment for 12 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Breast cancer diagnosis
  • •Menopausal complaints score > 14 (MRS II)
  • •End of last chemotherapy or radiotherapy > 2 months
  • •Expected stable disease for the next 6 months

排除标准

  • •Regular intake of glucocorticoids
  • •Regular practice of hydrotherapy before inclusion
  • •Start or change of other treatments/changes of lifestyle in order to influence menopausal symptoms
  • •Psychiatric disorders with possible influence on compliance and adherence to the protocol
  • •Other severe or progressive diseases with influence on compliance and adherence to the protocol
  • •Contraindications to hydrotherapy (severe heart failure, relevant dermatological diseases, Raynaud's Phenomenon [M. Raynaud], peripheral arterial occlusive disease Fontaine stage IIb [VK IIb] or more, acute thrombosis, or thrombophlebitis)

研究组 & 干预措施

immediate treatment group (SBG)

Experimental

immediate start of hydrotherapy (self treatment) in immediate treatment group (SBG)

干预措施: hydrotherapy according to Kneipp rules (Other)

waiting group (WG)

No Intervention

start of hydrotherapy (self treatment) after waiting period of 12 weeks

结局指标

主要结局

Menopausal complaints (MRS II)

时间窗: 12 and 24 weeks

次要结局

  • Cortisol profile (saliva)(12 and 24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Cornelia von Hagens

Head Complementary & Integrative Medicine, Dep. 4.2

Heidelberg University

研究点 (1)

Loading locations...

相似试验